Minerva Neurosciences (NERV) Interest Expenses (2014)

Minerva Neurosciences (NERV) has 14 years of Interest Expenses data on file, last reported at $16.3 million in Q1 2026.

• Quarterly Interest Expenses changed N/A year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (changed N/A YoY) and the FY2025 annual result came in at $99.7 million, up 3.76% from the prior year.
• Interest Expenses advanced to $16.3 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $96.9 million in Q4 2023 to a low of $17000.0 in Q2 2024.
• A 5-year average of $30.4 million and a median of $1.6 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses surged 216.16% — and 2024, when it tumbled 99.16%.
• Tracing NERV's Interest Expenses over 5 years: stood at $90.1 million in 2022, then increased by 7.5% to $96.9 million in 2023, then declined by 0.84% to $96.1 million in 2024, then slumped by 98.68% to $1.3 million in 2025, then jumped by 1181.1% to $16.3 million in 2026.
• The last three Interest Expenses figures came in at $16.3 million (Q1 2026), $1.3 million (Q4 2025), and $96.1 million (Q4 2024), per Business Quant data.